Your browser doesn't support javascript.
loading
[Comparison of efficacy and safety of insulin aspart injection Rishulin and NovoRapid for treatment of diabetes: a multicenter, randomized, open-labeled, controlled trial].
Jia, W P; Bao, Y Q; Miao, H; Tu, P; Liu, Y; Yang, T; Wang, W B; Shi, B Y; Liu, M; Hua, W J; Hou, N N; Zhang, Q; Hu, L; Pang, S G; Liu, J D; Wang, G X.
Afiliação
  • Jia WP; Department of Endocrinology, Shanghai Jiaotong University Affiliated Sixth People's Hospital, Shanghai 200233, China.
  • Bao YQ; Department of Endocrinology, Shanghai Jiaotong University Affiliated Sixth People's Hospital, Shanghai 200233, China.
  • Miao H; Department of Endocrinology, Second Affiliated Hospital of Nanjing Medical University, Nanjing 210011, China.
  • Tu P; Department of Endocrinology, Nanchang Third Hospital, Nanchang 330009, China.
  • Liu Y; Department of Endocrinology, Second Hospital of Jilin University, Changchun 130041, China.
  • Yang T; Department of Endocrinology, Jiangsu Province People's Hospital, Nanjing 210029, China.
  • Wang WB; Department of Endocrinology, Shougang Hospital of Peking University, Beijing 100144, China.
  • Shi BY; Department of Endocrinology, First Affiliated Hospital of Xi'an Jiaotong University, Xi'an 710061, China.
  • Liu M; Department of Endocrinology, General Hospital of Tianjin Medical University,Tianjin 300020,China.
  • Hua WJ; Department of Endocrinology, Wuxi Third People's Hospital, Wuxi 214043, China.
  • Hou NN; Department of Endocrinology, Affiliated Hospital of Weifang Medical College, Weifang, Shandong 261033, China.
  • Zhang Q; Department of Endocrinology, First Affiliated Hospital of Anhui Medical University, Hefei 230022, China.
  • Hu L; Department of Endocrinology, Nanchang First Hospital, Nanchang 330008, China.
  • Pang SG; Department of Endocrinology, Ji'nan Central Hospital, Ji'nan 250013, China.
  • Liu JD; Department of Endocrinology, Jiangxi Province People's Hospital, Nanchang 330006, China.
  • Wang GX; Department of Endocrinology, First Hospital of Jilin University, Changchun 130021, China.
Zhonghua Nei Ke Za Zhi ; 60(12): 1148-1156, 2021 Dec 01.
Article em Zh | MEDLINE | ID: mdl-34856687

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Diabetes Mellitus Tipo 2 / Insulina Aspart Idioma: Zh Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Diabetes Mellitus Tipo 2 / Insulina Aspart Idioma: Zh Ano de publicação: 2021 Tipo de documento: Article